ST. LOUIS--(BUSINESS WIRE)--Biomedical Systems – a 40-year-old, family-owned leading clinical trial provider to Pharmaceutical, Medical Device, Biotech, and Contract Research Organizations (CROs) – has announced the appointment of Robin Marc Akers as the new Vice President of Business Development.
Mr. Akers brings over 20 years of life science sales and sales leadership experience to Biomedical Systems. He joins Biomedical Systems from Southern Research Institute where he led the Global Business Development Team for the Drug Development Division. He has held other senior sales positions at organizations such as Thermo Fisher Scientific, DuPont and DynaVox Technologies.
“Rob has an incredible pedigree of sales leadership. He has successfully led numerous teams to exemplary performance throughout his career. This history of success, combined with his knowledge of the clinical trial market make him an ideal fit for this assignment. We believe Rob will help our organization further penetrate the market and capitalize on our position as the most comprehensive provider of centralized clinical trial services,” said Bob Mills, Executive Vice President of Sales and Marketing.
“I am thrilled to join Biomedical Systems,” said Rob. "The company has a long history, under the same family ownership, and a solid reputation in the market place. I am excited to apply some of my experience leading sales teams to accelerate growth, increase revenue and market share for the organization.”
Mr. Akers earned a Bachelor of Science in Business Administration from The Citadel in 1986 and holds Masters degrees from Paris-Sorbonne University (MA) and Webster University (MBA).
About Biomedical Systems
Biomedical Systems is a premier global provider of centralized diagnostic services.
Founded in 1975, Biomedical Systems has grown to be a leading clinical trial provider to Pharmaceutical, Medical Device, Biotech, and CROs. Its comprehensive clinical trial solutions include Cardiac Safety, Pulmonary Function, Imaging, eCOA, and Scientific Affairs.
Biomedical Systems’ corporate headquarters are located in St. Louis, Missouri. European headquarters are located in Brussels, Belgium with supporting offices in Japan, China and India which are able to resupply equipment and materials to challenging areas around the world in a timely, cost effective manner. Its global, multi-lingual staff speaks 21 languages facilitating communication with international sponsors and sites delivering better quality data. With five strategically located offices spanning the globe, Biomedical Systems has managed thousands of clinical trials in over 95 countries and can offer services and support 24 hours a day. For more information, visit http://www.biomedsys.com/.